FDA Investigator Anna E Fain
Anna E Fain has inspections in 1 countries as of 18 Sep 2023. Anna E Fain has collaborated with a combined 1558 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
58
Last Inspection Date:
18 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker,
Amanda B Athey,
Amanda M Osteen,
Ann B Borromeo,
Barbara D Wright,
Benjamin E Bowen,
Billst,
Bonnie E Conley,
Bonnie E Pierson,
Brandon C Heitmeier,
Briggs,
Caitlin L Almonrode,
Carolyn E Barney,
Carter,
Chantel Evans Dixon,
Charles N Dupont,
Cherie T Parker,
Cheryl G Scott,
Claire M Minden,
Clendening,
Cody D Rickman,
Coral Del M Lopez,
Cynthia L Medlin,
Daniel L Aisen,
Danielle M Maddox,
David R Heiar,
Debra A Sherman,
Decima L Washington,
Demario L Walls,
Donna D Gallien, MPH,
Dr. Koffi A Amegadje,
Edward H Maficka,
Edward H Maticka,
Emily E Smith,
Fabian Nchaparro Rodriguez,
Ferrante,
Frank Flores,
Gail L Katz,
Gibson,
Gretchen M Laws,
Hultman,
Johnathan M Crayton,
Justin N Henson,
Karen Gale Sego,
Karen R Smallwood,
Kari L Batey,
Kenneth R Merritt,
Kimberly A Joseph,
Kimberly L Mcmillan,
Kip J Hanks,
Krista W Whitten,
Lacey J Chessor,
Laura L Staples,
Leon L Crawley,
Linda Agregory Duty,
Llopis,
LTJG Lauren N Shade,
M Aabel I,
Mahaffey,
Maressa L Mills,
Margaret E Slimbach,
Marie F Morin,
Mark W Rivero,
Marlene L Davis,
Marshall H Kinsey,
Mary A Millner,
Matthew G Ellison,
Matthew R Mcnew,
Melanie L Drayton,
Myla T Collins,
Norman Wong,
Patricia S Smith,
Patrick C Dooley,
Randy D Baxter,
Randy L Clarida,
Robert E Hultman,
Ronnie E Jackson,
Samantha J Bradley,
Sanders,
Scott A Watson,
Shirhonda D Thorn,
Shondra N Gipson,
Smith,
State Agency,
Stephanie A Cochran,
Stephen G Mclane,
Steven D Dittert,
Susan O Oladeji,
Thomas B Smith,
Travis E Chapman,
Wendy R Blame,
Whitney M White,
Zachary J Conlin,
Zada L Giles
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more